CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of ...
The Centers for Medicare & Medicaid Services (CMS) has published a proposed local coverage determination (LCD) for a not reasonable and necessary determination for Group 2 power wheelchairs (PWCs) wit ...
NEW YORK, July 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc ...
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare ...
Following a ~38% sell-off in the previous session, CareDx (NASDAQ:CDNA) traded higher on Friday after the company said it doesn’t expect the use of its testing products to change in response to the ...
The coalition letter, signed by senior advocacy, taxpayer, and consumer groups pointed out that the current process has been corrupted by bureaucrats who have been left unaccountable to patients and ...
As providers keep hearing over and over-from RACs and their own Medicare contractors, insufficient documentation is frequently the reason for claim denials. Whether these denials come up front from ...
The Centers for Medicare & Medicaid Services (CMS) uses coverage determinations to decide how Medicare should cover treatments, services, and items. These rules usually apply nationwide. The CMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results